(Some have theoretical worries that, for instance, BPC-157 might promote the growth of tumor cells.) On the other is an increasingly large and vocal cohort of experts and regular people who feel that the FDA, the pharmaceutical industry, and esteemed scientific institutions are gatekeeping potentially miraculous substances
Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: Differences and similarities
Reference: Gwyer D, Wragg NM, Wilson SL (2019)
That said, there is no robust clinical evidence that CJC-1295 or Ipamorelin regrow hair, and elevating GH/IGF-1 carries its own considerations, including effects on glucose metabolism and theoretical concerns about stimulating unwanted tissue growth
Furthermore, as with PTHrP [35], clinical studies need to be performed to assess its possible role in the treatment and prevention of hair loss